Laurence S. Sperling

Laurence S. Sperling is a Professor of Medicine at Emory University School of Medicine. He serves as the founder and director of Preventive Cardiology, co-director of the Cardiovascular Disease Fellowship Program, and medical director of multiple programs including The HeartWise Risk Reduction Program and Emory’s LDL apheresis program. He has also contributed to significant clinical trials such as JUPITER, COURAGE, and BARI-2D.

Research Interests: Dr. Sperling specializes in heart disease prevention, lipid metabolism, and cardiovascular interventions. His work spans clinical trials, risk reduction strategies, and advanced therapies like LDL apheresis.

Scientific Awards:

• Fellow of the American College of Cardiology (FACC)
• Fellow of the American College of Physicians (FACP)
• Fellow of the American Heart Association (FAHA)

Publications: Dr. Sperling has authored over 80 manuscripts, abstracts, and book chapters, focusing on cardiovascular disease prevention and lipidology. His contributions include pivotal studies in clinical cardiology and metabolic disorders.